Preliminary clinical experience with the antiarrhythmic effect of PGF2a

A total dosage up to 1 mg PGF_2a as i.v. infusions of 10–40 μg/min. was investigated on patients with arrhythmias of several kinds. We found therapeutic effects in 5 of 6 patients with constant extrasystoles and in one patient with digitalis - induced partial AV-block respectively. In 3 of 4 patients with acute tachyarrhythmias the results were not convincing, probably due to a dosage not high enough. An increase of the diastolic stimulation threshold usually seen with other antiarrhythmics was not to be observed in 3 patients. The mechanism of action of PGF_2a has not yet been clarified.     

Some constituents of Pitavia punctata

Extracts from the stems and leaves of Pitavia punctata Mol. were examined. The neutral fraction yielded β-sitosterol, daucosterin, quercetin, avicularin, and the previously undescribed quercetin 3-rhamnosylarabinoside. Braylin was co-extracted with the basic constituents, dictamnine, skimmianine and γ-fagarine. Acid hydrolysis of the leaves yielded cyanidin and delphinidin.